Pediatric Psych Treatment Flashcards

(41 cards)

1
Q

Stimulants- Available Drugs

A

Methlyphenidate
Dexemethylphenidate
Amphetamine Salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Stimulants- Mech of Action

A

Block reuptake of NE and DA in presynaptic neurons

Increase DA in synaptic cleft

Da improves attention
NE dampens noise, increases inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Stimulants- Absorption, Distribution

A

Can be short or long acting
Titrate to optimum dose
MPH has faster onset, but Adderall (amphetamine salts) has longer lasting effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Stimulants- Adverse Effects/Contraindications

A

Black box warning= chance of sudden death–> contraindicated in structural cardiac abnormalities, cardiomyopathy, serious rhythm abnormalities

temporary growth slowing

Adderall= more stomachaches and sad mood than MPH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Methylphenidate- Clinical Use

A

first line for ADHD

patients at least 6 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Amphetamine salts- Notes

A

Patients at least 3 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Methylphenidate- Brand Names

A
Ritalin
Ritalin LA/SA 
Metadate CD/ER
Concerta
Daytrana
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Dexemthylphenidate- Brand Names

A

Focalin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Amphetamine Salts- Brand Names

A

Dextroamphetamine
Mixed amphetamine salts- ADDERALL
Vynase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-Stimulants (Selective NE Reuptake Inhibitors)- Available Drugs

A

ATOMOXETINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Selective NE Reuptake Inhibitor (Atomoxetine)- Mech of Action

A

Inhibit presynaptic NE transporter, Increase NE in synaptic cleft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Selective NE Reuptake Inhibitor (Atomoxetine)- Absorption, Distribution

A

dosed by weight

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Selective NE Reuptake Inhibitor (Atomoxetine)- Clinical Use

A

suggested second line for ADHD

patients at least 6 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Selective NE Reuptake Inhibitor (Atomoxetine)- Adverse Effects/Contraindications

A

caution in children that are Cyp2D6 slow metabolizers= higher peak concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SSRIs- Available Drugs

A
FLUOXETINE
Citalopram
ESCITALOPRAM
FLUVOXAMINE
SERTALINE
Paraoxetine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SSRIs- Mech of Action

A

increase 5-HT in the synaptic cleft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SSRIs- Adverse Effects/Contraindications

A

Black box warning= increased risk of suicidal thinking and behaviors during first few months of treatment

18
Q

Fluoxetine- Clinical Use

A

MDD- age >8y/o

OCD- age >7y/o

19
Q

Escitalopram- Clinical Use

A

MDD- age 12-17

20
Q

Fluvoxamine- Clinical Use

A

OCD age >8y/o

21
Q

Sertaline- Clinical Use

A

OCD age >6y/o

22
Q

Citalopram, Escitalopram- Notes

A

Most selective for 5-HT, no effect on NE

23
Q

Sertaline, Paroxetine- Notes

A

Most potent 5-HT reuptake inhibitors

24
Q

SNRIs- Available Drugs

A

Venlafaxine
Mirtazapine
Duloxetine
Desvenlafaxine

25
SNRIs- Mech of Action
increase 5-HT, DA, and NE in the synaptic cleft
26
SNRIs- Clinical Use
off-label use only
27
SNRIs- Adverse Effects/Contraindications
Black box warning= increased risk of suicidal thinking and behaviors during first few months of treatment
28
Typical Antipsychotics- Available Drugs
Haloperidol Chlorpromazine Thioridazine
29
Typical Antipsychotics (Haloperidol, Chlorpromazine, Thioridazine)- Mech of Action
Block postsynaptic D2 receptors and presynaptic dopamine autoreceptors
30
Typical Antipsychotics (Haloperidol, Chlorpromazine, Thioridazine)- Clinical Use
Acute, short-term for aggression, delirium, or when treatment with atypical antipsychotics fail
31
Typical Antipsychotics (Haloperidol, Chlorpromazine, Thioridazine)- Adverse Effects/Contraindications
NMS (NEUROLEPTIC MALIGNANT SYNDROME) | Contrindicated in prolonged QT interval, ventricular tachycardia, arrhythmias
32
Atypical Antipsychotics- Available Drugs
``` RISPERIDONE Clozapine Olanzapine Quetiapine Ziprasidone Aripiprazole ```
33
Atypical Antipsychotics (RISPERIDONE, Clozapine, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole)- Elimination
metabolized by CYP450 system
34
Atypical Antipsychotics (RISPERIDONE, Clozapine, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole)- Adverse Effects/Contraindications
NMS (NEUROLEPTIC MALIGNANT SYNDROME) safer than the typical antipsychotics Risperidone- increased appetite, fatigue, dizziness, drooling Contraindicated in prolonged QT interval, ventricular tachycardia, arrhythmias
35
Lithium Carbonate- Mech of Action
Blocks Phosphoinositol (PI) activity Inhibit cAMP Stabilize neuronal excitement
36
Lithium Carbonate- Elimination
Excreted unchanged by the kidney | Children have higher clearance & shorter half life than adults= reach steady state faster
37
Lithium Carbonate- Clinical Use
First line treatment for bipolar in children- age >12 irritability impulsivity aggression may have protective effect against suicidality
38
Lithium Carbonate- Adverse Effects/Contraindications
GI symptoms, polyuria, polydipsia, enuresis, fatigue, fine hand tremor, osmotic diarrhea Contraindicated in renal disease, cardiovascular disease, dehydration, hyponatremia, co-administration of diuretics or ACE inhibitors
39
Antiepileptics- Available Drugs
``` DIVALPROEX SODIUM Carbemazepine Oxacarbazepine Lamotrigine Topiramate Gabapentin ```
40
Divalproex Sodium- Clinical Use
First line treatment for Bipolar in children- age >18 irritability impulsivity aggression
41
Divalproex Sodium- Adverse EffectContraindications
GI symptoms, weight gain, drowsiness, hair loss hepatotoxicity, liver failure rarely pancreatitis, thrombocytopenia, polycystic ovaries